By David Matthews ( November 7, 2018, 8:24 PM EST) -- An Akorn Inc. shareholder sued the pharmaceutical company's executives and board members on Tuesday in Illinois federal court over falsified submissions to the U.S. Food and Drug Administration, a "debacle" that sunk a multibillion-dollar merger and plunged Akorn's share price by nearly 50 percent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.